TP53 mutation influences the efficacy of treatment of colorectal cancer cell lines with a combination of sirtuin inhibitors and chemotherapeutic agents.
Exp Ther Med
; 20(2): 1415-1422, 2020 Aug.
Article
in En
| MEDLINE
| ID: mdl-32742376
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Exp Ther Med
Year:
2020
Type:
Article